Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PER2 | O15055 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133648 | 0.88 | CYP2D6 (0.36) | KMT2APOLBCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL9815041 | 0.79 | DPP4 (0.33) | POLB | |
| SCHEMBL9815040 | 0.77 | L3MBTL1 (0.40) | PER2KMT2APOLBCYP2D6CYP2C9 | |
| SCHEMBL10850820 | 0.77 | KMT2A (0.35) | KMT2APOLBCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL9930180 | 0.77 | — | — | |
| SCHEMBL477750 | 0.74 | — | — | |
| SCHEMBL4447573 | 0.74 | — | — | |
| SCHEMBL10868666 | 0.74 | ALOX15 (0.33) | KMT2APOLBCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL9814986 | 0.74 | L3MBTL1 (0.41) | POLBL3MBTL1 | |
| SCHEMBL6365391 | 0.72 | PER2 (0.46) | PER2PIK3CDL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250075051-A1 | PROCESS FOR RECYCLING CONTAMINATED POLYMERS | ARKEMA FRANCE (FR) | 2025-03-06 | — | — | US | claimed |
| EP-4457275-A1 | PROCESS FOR RECYCLING CONTAMINATED POLYMERS | ARKEMA FRANCE (FR) | 2024-11-06 | — | — | EP | claimed |
| WO-2023126441-A1 | PROCESS FOR RECYCLING CONTAMINATED POLYMERS | ARKEMA FRANCE (FR) | 2023-07-06 | — | — | WO | claimed |
| EP-4206267-A1 | PROCESS FOR RECYCLING CONTAMINATED POLYMERS | ARKEMA FRANCE (FR) | 2023-07-05 | — | — | EP | claimed |
| US-20200138787-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-05-07 | — | — | US | claimed |
| US-10292967-B2 | Compositions comprising corneoscleral tissue cross-linking agents | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-05-21 | — | — | US | claimed |
| US-20190015388-A1 | COMPOSITIONS COMPRISING CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2019-01-17 | — | — | US | claimed |
| US-10105350-B2 | Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking agents | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2018-10-23 | — | — | US | claimed |
| US-20160374992-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2016-12-29 | — | — | US | claimed |
| EP-2412733-B1 | Polymer, chemically amplified negative resist composition, and patterning process | SHINETSU CHEMICAL CO (JP) | 2016-03-23 | — | — | EP | claimed |
| US-8470512-B2 | Polymer, chemically amplified negative resist composition, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2013-06-25 | — | — | US | claimed |
| US-20120028190-A1 | POLYMER, CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-02-02 | — | — | US | claimed |
| EP-2412733-A1 | Polymer, chemically amplified negative resist composition, and patterning process | Shin-Etsu Chemical Co., Ltd. (JP) | 2012-02-01 | — | — | EP | claimed |
| US-20080187735-A1 | Non-Woven Fabric and Food Casing Which is Produced Therefrom and Which is Based on Cellulose Hydrate | KALLE GMBH (DE) | 2008-08-07 | — | — | US | claimed |
| US-4864026-A | Method of manufacturing N-alkyl-N'-methyl-alkyleneureas, particularly N,N'-d | HULS AKTIENGESELLSCHAFT (DE) | 1989-09-05 | — | — | US | claimed |
| US-4438189-A | POLYUNSATURATED COMPOUND, CROSSLINKABLE EPOXY OR METHYLOL COMPOUND | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-03-20 | — | — | US | claimed |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | disclosed |
| CN-116130796-B | Intrinsic safety efficient electrolyte for rechargeable zinc ion battery and preparation and application thereof | 上海交通大学 | 2025-05-06 | — | — | CN | disclosed |
| EP-0028204-A2 | Pre-extended etherified aminoplast resins, process for their preparation and their use in surface coatings | CIBA-GEIGY AG (CH) | 1981-05-06 | — | — | EP | disclosed |
| US-3983043-A | Mixtures of methylolalkyl ureas and their butyl ethers | BASF AKTIENGESELLSCHAFT (DT) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190015388-A1 | COMPOSITIONS COMPRISING CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | SMCHD1, ALDH1A2, CRYAB | TSHR 3434/4885PER2 2002/4885PIK3CD 4322/4885 |
| US-10105350-B2 | Cosmetic preservatives as therapeutic corneoscleral tissue cross-linking agents | COL1A1, COL14A1, COL2A1 | TSHR 2745/4885PER2 1361/4885PIK3CD 4502/4885 |
| US-20200138787-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | ALDH1A2, FAAH, FAAH2 | TSHR 2194/4885PER2 1374/4885PIK3CD 4497/4885 |
| US-10292967-B2 | Compositions comprising corneoscleral tissue cross-linking agents | SMCHD1, ALDH1A2, CRYAB | TSHR 3434/4885PER2 2002/4885PIK3CD 4322/4885 |
| US-20160374992-A1 | COSMETIC PRESERVATIVES AS THERAPEUTIC CORNEOSCLERAL TISSUE CROSS-LINKING AGENTS | COL1A1, COL14A1, COL2A1 | TSHR 2745/4885PER2 1361/4885PIK3CD 4502/4885 |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | TTR, TAS2R5, TAS2R50 | TSHR 2090/4885PER2 823/4885PIK3CD 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.